[Transcatheter Aortic Valve Implantation in Multivalvular Heart Disease].

Fritschi, Daniel; Oechslin, Luca; Biaggi, Patric; Wenaweser, Peter (2023). [Transcatheter Aortic Valve Implantation in Multivalvular Heart Disease]. Praxis - schweizerische Rundschau für Medizin, 112(2), pp. 65-73. Huber 10.1024/1661-8157/a003982

Full text not available from this repository.

Transcatheter Aortic Valve Implantation in Multivalvular Heart Disease Abstract. The prevalence of multivaluvular heart disease is high in patients undergoing transcatheter aortic valve implantation (TAVI). The most common combination is aortic valve stenosis (AS) and mitral regurgitation, followed by the combination of AS with a tricuspid regurgitation or mitral stenosis. Grading of multivalvular disease is challenging and can quickly lead to underestimation of the disease stage. Therefore, a profound knowledge of pathophysiologic interactions is essential, and the patient should always undergo multimodal evaluation. After a successful TAVI intervention, secondary heart valve defects may improve, deteriorate, or remain unchanged. Due to the still sparse scientific data in this field, the role of the heart team remains central to provide the patient with an individually adapted therapy plan.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Wenaweser, Peter Martin

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1661-8157

Publisher:

Huber

Language:

German

Submitter:

Pubmed Import

Date Deposited:

07 Feb 2023 12:47

Last Modified:

07 Feb 2023 23:27

Publisher DOI:

10.1024/1661-8157/a003982

PubMed ID:

36722107

Uncontrolled Keywords:

Aortenklappenstenose Cardiopathie multivalvulaire Multivalvular heart disease Multivalvuläre Herzerkrankung TAVI aortic stenosis sténose de la valve aortique

URI:

https://boris.unibe.ch/id/eprint/178289

Actions (login required)

Edit item Edit item
Provide Feedback